chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mother called to report that patient was fine after leaving office on 12/2/08 where patient rec'd YF-Vax and Typhim Vi immunizations and had no c/o the next morning.  Seen by a provider on 12/3/08 for flu immunization; became hot, dizzy, and tachycardic 15 minutes after receiving flu shot at work.  Sent to Hospital, HR reported 157.  Rxed w/ K+ & hydration. Kept overnight.  D/Ced next day, experienced another episode while at a provider's office and was sent to Hospital for ED eval.  D/C w/ neg w/u per mother's report.  To see PCP today (12/5/08).  12/11/2008 ER record received for DOS 12/04/2008 with DX:  Tachycardia.  palpitations.  Pt presented to ER for 2nd time in with c/o rapid heart rate and shaking. Told K+ low at previous ER visit. Pulse 106 on arrival. D/C home after (-) w/u.   12/22/08  ER record received for 12/3/08 with DX:  Tachycardia improved. Pt presented after developing sweating and heart racing following Flu shot. HR 120. Tx with IVF w/ KCl. D/C to f/u with PCP
After one day I experiences very sharp sting episodes throughout head area locations differed and intervals were from sudden and lasting 1 min. and then lasting 10 seconds or so.   Episodes are  further apart to date.  Most recently I have been experiencing very pin pointed sharp stinging like sensations at both ankles, both elbows at  knee thigh area  and sometimes right finger tips.  Episodes come and go and are usually lasting a few seconds.   Right side of face pinching feeling under right eye.
Patient reported to the Clinic on 11/16/2017 at 18:00 with complaint of Left shoulder pain and fever. The patient had an influenza vaccine and an pneumonia vaccine given yesterday in the left upper deltoid. Six to seven hours later she was experiencing significant pain in the shoulder and difficulty moving the shoulder due to pain. She also had experienced a fever of 102. She was not able to sleep laying down last night because that exacerbated the pain so she tried to sleep sitting up. Fever persists through today and now has been present for greater than 24 hours. She has been holding her arm in a sling for comfort and using ibuprofen. She is rating her pain at rest at a 2/10 and with movement 6/10 to 7/10. Plan: 1. Imaging of the left shoulder by MRI scheduled for 11/17/2017. 2. Patient was given 1.2 million units BICILLIN LA intramuscularly 11/16/2017 at 19:00. 3. Advised to seek Emergent care at the Emergency Department if worsens overnight. 4. For pain management she will use oxycodone 5 mg every four hours as needed for pain. 5. Proceed to MRI left shoulder tomorrow. If this exam is not available as an outpatient I have recommended that the patient present to the Emergency Department for further evaluation.
Soreness on her right arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th January 2020, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported that after receiving the 1st dose of Shingrix she experienced soreness on her right arm that resolved after a couple of days.  The reporter consented to follow up. For tolerance to 2nd dose refer linked case US2020217491, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020217491:Same patient
This case was reported by a pharmacist and described the occurrence of not responding to therapy in a 71-year-old female subject who was vaccinated with HAVRIX, (GlaxoSmithKline).  Concurrent medical conditions included possible cirrhosis and sulfa allergy.  Concurrent vaccination included RECOMBIVAX, (Sanofi Pasteur MSD) given on an unspecified date.  Concurrent medications included PRAVASTATIN and LIBRAX.  On 5 October 2007 and 20 March 2008 the subject received 1st dose and 2nd dose of HAVRIX (1440 units, unknown route, unknown deltoid).  On an unknown date in 2009 (in the past 2-3 months), the subject experienced negative antibodies (not responding to therapy).  A physician from a liver institute called the reporter to inquire about these results.
Vaccine injection site developed into a big red welt since 1/4/21. Potential infection. Started on antibiotics 1/5/21.
This man's wife called this morning to report that her husband blood sugar had registered HIGH on his home glucose monitor last evening at home.  He used his sliding scale insulin.  This morning his blood sugar is  "just over 300" and they have a call into his doctor at  Hospital in city.They were unsure if this was related to the vaccine but wanted to report it.
Had a busted blood vessel in my eye within 3 days  Never had one before, ever! Then the following month I started have severe menstrual cycles. Passing clots like crazy, excessive bleeding like I've never had before. Cramps that took me to my knees.  I will literally bleed down my legs. I have never had anything like this, even after a miscarriage.
within 10-15 minutes post vaccination the recipient notified nurse she had difficulty in breathing, complaining of rapid heart rate, not feeling well, lightheaded, chest pressure, tingling. No LOC.  Called 911 , Epi auto injection given 0.3 mg; reported improvement in chest pressure and breathing shortly afterwards, taken to local hospital via EMS in stable condition. Total time in clinic: approximately 40 minutes from vaccination to EMS leaving.
Fevers, chills, headaches, body aches 24-48 hours after; sore throat 48-96 hours after; pink papular rash on upper chest, arms, neck, and face 113 hours after administration. (NOT hives.) Hard, red, tender, itchy, indurated area size of deck of cards on left arm injection site, ongoing 9 days after injection. Because of COVID protocols and mpx exposure, I was tested for Covid PCR x 2, viral respiratory panel x 1, swabbed for MPX (no result, 96+ hours after swab), and kept out of work for an entire week so far.   1 week of work missed as a nurse practitioner in a primary care clinic with serious staffing difficulties already, during a public health emergency. Isolation away from my two young children, distressing to both the children and the parent.   There's no data on papular rash after Jynneos. Does it occur? Was this a vaccine reaction? Was this unrelated?  How are MPX-exposed individuals getting PEP vaccination supposed to distinguish between vaccine reaction vs acute illness?  What are the healthcare staffing consequences of these reactions? Should people be kept out of work?   Should MPX swabs of HCWs be expedited? If negative, is that even enough to clear to return to work or does the HCW have to wait until all symptoms have fully resolved?   Can symptoms be treated with antihistamines or topicals or any other measures to resolve them faster to allow return to essential work? If these treatments are effective, does that mean it was vax related and not infection?
Developed cellulitis of left deltoid on 10/15/2002 and treated with Keflex snop 250/5cc  1 1/2 tsp BID x 10 day. He received IPV osu SQ and MMR # 2 osu SQ on 10/14/2002  im left tricep
05/01/00 - Pt received DT booster; 05/03/00 Pt developed redness and soreness at injection site; went to ER. Physician diagnosed allergic/immune response to DT booster left arm. Pt was treated with Claritin and Benadryl.
I suffered from severe plugged left ear. I have loss all hearing in that ear. I then starting suffering from vertigo and I still deal with it currently. I saw a doctor in another country.
Information has been received from a nurse practitioner concerning a 14 year old female who in April 2008, was vaccinated a first dose of GARDASIL 0.5 mL IM. There was no concomitant medication. In April 2008, the patient experienced nausea and fever within 30 minutes of her first GARDASIL vaccination. Medical attention was sought. This was the patient's first and only dose of GARDASIL. Subsequently, the patient recovered from nausea and fever the next day. Additional information has been requested.
Patient is experiencing excruciating pain at injection site and palpitation unable to lift arm since receiving 2nd dose of SHINGRIX. No swelling or redness.
On July31st I had stroke. I had an MRI done , multiple exams , etc I was admitted into Hospital from July31st until August 5th and then was transferred to Rehab and was there from August 5th until August 22, 2022.  All cardiac testing to date have been negative . The cause of the stroke has been deemed unknown but these are the following topics discussed : possible combination of diabetes , history of high blood pressure ( my Endocrine doctor has stated to me while my blood sugars were off they were not off enough to cause a stroke in her medical opinion ) and the Covid 19 booster which was received on 6/13/22.. I should state even though these factors exist on both sides of my family worse than what I have , there is no family history to my knowledge of stroke. My neurologist says the booster cannot be taken off the table and my allergist concurs . Both neurologist and Dr ( my allergist ) are aware that this letter is being sent in . I specifically asked allergist if I should report this to you and his response was if I physically felt up to it,  Here are some facts for you to review  Pfizer Covid shot #1 8/27/21 . Throat got scratchy, vomitted once , left eye ( side if vaccine ) started twitching.  Pzifer Covid shot #2 9/15/21 . Throat got scratchy again this time instead of only a few hours it lasted several days , left sided eye twitching which had not fully resolved intensified , I got 2 very itchy hives around the vaccine site and the next day I got a small rash which more than doubled in size by 9/19/21 and lasted a couple of weeks. Also, near the vaccine sight I developed a red lump which did not go away . On March 3/2/22 , the lump was still there so Dr , my dermatologist at that time removed it and biopsied it and it was deemed a benign mole .   On June 13, 2022 I received the booster at my allergist office due to worsening responses to the vaccine ( the first to shots were done at Pharmacy ) . It should be noted that I made it very clear that I was only receiving the Covid 19 vaccines and booster because I was forced to as a requirement to maintain my employment with my employer and medical exemptions were next to impossible to obtain . My daughter was physically present with me when I received the booster . At the doctors office , while being monitored my voice got hoarse and very scratchy , I was very itchy all over and was given PO benadryl . My blood pressure also spiked . I was sent home with the advisement to take benadryl . Once I stopped the benadryl ,  broke out in hives on my foot . I missed nearly a week of work , The booster was given on a Monday and I happened to have an appt with my endocrine on Thursday . At this point , you could not touch the left side of my upper body . It was swollen and tender to the touch. My endocrine , Dr said she could see and feel  the swelling in that area but there was no swollen lymph nodes . She saw the hives on my foot and my blood pressure was still off. It was my understanding that not only did I have an allergic reaction but I also had an  inflammatory response..I was advised to rest , drink water etc.
Immediate onset pain (L) arm, deltoid area with no progression to point she has marked limitation of shoulder movement.
Expired Bexsero administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB37AA, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 9th August 2022, the patient received the 1st dose of Bexsero and Bexsero Pre-Filled Syringe Device. On 9th August 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 09-AUG-2022 Reporter's comment: The healthcare professional from medical office reported 16 year old patient was administered a dose of Bexsero on 09th August 2022, which was expired on of 31st July 2022.  At the time of reporting, dose had not been repeated.  The Vaccine Administration Facility was the same as Primary Reporter The reporter consented to follow up. Additional Supportive Information: The patient received an expired dose of Bexsero vaccine, which led to expired vaccine used.
This case was reported by a physician via sales rep and described the occurrence of syncopal attack in a 63-year-old female patient who received SHINGRIX for prophylaxis. On 8th February 2019, the patient received the 1st dose of SHINGRIX .5 ml. On 8th February 2019, less than a day after receiving SHINGRIX, the patient experienced fever, general body pain, headache, injection site warmth, injection site swelling, injection site erythema and injection site induration. On 9th February 2019, the patient experienced syncopal attack (serious criteria GSK medically significant) and low blood pressure. On an unknown date, the outcome of the syncopal attack, fever, general body pain, headache, injection site warmth, injection site swelling,  site erythema, injection site induration and low blood pressure were unknown. It was unknown if the reporter considered the syncopal attack, fever, general body pain, headache, injection site warmth, injection site swelling, injection site erythema, injection site induration and low blood pressure to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX vaccine on in the left deltoid within 24 hours of receipt of vaccine had a fever of 100 degree F, body aches and a severe headache. The injection site was warm and patient had red swelling induration. The patient went to work the following day after vaccine administration and had a syncopal episode due to blood pressure being 90/56. The patient was sent home from work and stayed in the bed all weekend. The reporter did not agree to follow up from GlaxoSmithKline.
pain never gets better gets worse; severe reaction; Initial information was received on 30-Jan-2021 regarding an unsolicited valid serious case from a consumer or other non-professional via media.  This case involves an elderly patient (age and gender unspecified) who had suffered terribly severe reaction (adverse drug reaction) and pain never got better, got worse (pain), after patient received INFLUENZA VACCINE.  At the time of event patient had ongoing pain.   The patient had no other medical history, concomitant disease or risk factor.  Past medical treatment, vaccination, family history and concomitant medication were not provided.  In 2018, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details not reported] for prophylactic vaccination.  On an unknown date, the patient suffered a non-serious terribly severe reaction (adverse drug reaction) and her pain never got better, got worse (pain), (unknown latency) following the administration of INFLUENZA VACCINE.  These events were assessed as medically significant as per the reporter.  It was reported that, patient received over 65 flu vaccine and patient was afraid to get the corona virus (COVID) vaccine.  It was unknown if the patient experienced any additional symptoms/events.  There were no laboratory data/results available.  It was not reported if the patient received any corrective treatment.  At the time of reporting, patient was not recovered from the reported events.   There will be no information available on the batch number for this case.; Sender's Comments: This media case involved an elderly patient (age and gender unspecified) who had adverse drug reaction and pain (pain aggravated), after administration of INFLUENZA VACCINE (unknown manufacturer). Time of onset is unknown. At the time of vaccination, patient had ongoing pain and no other medical history, concomitant disease or risk factor. Further information regarding past vaccination, treatment, concomitant medication and their tolerance also the laboratory investigation results were not reported and required for complete assessment of case. Based on reported information, role of suspect vaccine can not be assessed.
approximately 1.5 weeks after the first dose, I experienced sudden hearing loss in my left ear. I went to ENT doctor and he put me onn a steroid regimen for 2 weeks. that did no help the symptom.
horrible pain in left arm; tendonitis; Tennis Elbow; Can't use Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (horrible pain in left arm), TENDONITIS (tendonitis), EPICONDYLITIS (Tennis Elbow) and LIMB DISCOMFORT (Can't use Arm) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (horrible pain in left arm), TENDONITIS (tendonitis), EPICONDYLITIS (Tennis Elbow) and LIMB DISCOMFORT (Can't use Arm). At the time of the report, PAIN IN EXTREMITY (horrible pain in left arm), TENDONITIS (tendonitis), EPICONDYLITIS (Tennis Elbow) and LIMB DISCOMFORT (Can't use Arm) outcome was unknown. Not Provided          No concomitant medication included.  No treatment medication included.
Itching all over body starting shortly after injection and continuing to the next day. Rash/hives over body starting shortly after injection and continuing to next day. Advised patient to take BENADRYL and Antiseptic lotions.
Low grade fever few days ago, itchy and rash mostly on trunk- few on arm, legs, and face. Benadryl given for itching.
Headache, Myalgia, Fever, difficulty breathing, injection site pain Narrative: The morning after receiving a booster dose of the Moderna COVID-19 vaccine, the patient developed a headache, fever (temp unknown), injection site pain, and experienced some difficulty breathing. He took one dose of acetaminophen 500mg for his symptoms.
Patient received dose at 11:30am, proceeded to obs area.  Within minutes, she experienced c/o nausea, lightheaded feeling, and headache.  Denies SOB, chest pain, or pain otherwise in body.  Denies feeling of weakness.  Patient reports exact symptoms with first dose, lasting all day.  11:45 BP 110/75, pulse 75 steady.  Clinically stable, symptoms no worse.  Patient mother agreed to transport patient home to recover, plans on calling provider re: mast cell activation and symptom management.  Patient transported to personal vehicle via wheelchair without incident. NP
tinnitus; fatigue; ear issue; virus severely attacks nervous system; weakness/overuse: senses; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), on 28Dec2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: Jan2021, for COVID-19 immunization, reaction(s): "patient experienced load-grade dizziness after 1st vaccine". The following information was reported: EAR DISORDER (non-serious) with onset 28Dec2021, outcome "unknown", described as "ear issue"; FATIGUE (non-serious) with onset 28Dec2021, outcome "unknown"; TINNITUS (non-serious) with onset 28Dec2021, outcome "unknown"; NERVOUS SYSTEM DISORDER (non-serious) with onset 28Dec2021, outcome "unknown", described as "virus severely attacks nervous system"; ASTHENIA (non-serious) with onset 28Dec2021, outcome "unknown", described as "weakness/overuse: senses".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
- Swelling & pain in joints, fatigue - Under medical provider care, pending lab results & medical eval.
Generalized muscle aches, lasted about a day, but right knee got worse, painful, swollen and still is problematic.
Breaking out in itchy rashes throughout entire body. Happens once or twice a day and persists for a few hours. Zyrtec appears to help the swelling and itching.
Third COVID shot got chills and sore and fatty liver; Third COVID shot got chills and sore and fatty liver; Third COVID shot got chills and sore and fatty liver; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC STEATOSIS (Third COVID shot got chills and sore and fatty liver), PAIN (Third COVID shot got chills and sore and fatty liver) and CHILLS (Third COVID shot got chills and sore and fatty liver) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Previously administered products included for Product used for unknown indication: ALTACE, PRAVACHOL, FOSAMAX and CIPRO. Past adverse reactions to the above products included Drug allergy with CIPRO; and No adverse event with ALTACE, FOSAMAX and PRAVACHOL. Concurrent medical conditions included Drug allergy, Drug allergy, Allergy, Protein allergy, Drug allergy and Drug allergy.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced HEPATIC STEATOSIS (Third COVID shot got chills and sore and fatty liver), PAIN (Third COVID shot got chills and sore and fatty liver) and CHILLS (Third COVID shot got chills and sore and fatty liver). At the time of the report, HEPATIC STEATOSIS (Third COVID shot got chills and sore and fatty liver) was resolving and PAIN (Third COVID shot got chills and sore and fatty liver) and CHILLS (Third COVID shot got chills and sore and fatty liver) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: Fatty liver.         IT was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Patient past medication was penicillin for unknown indication.  No concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
pt recvd vax & devel pain & redness @ inject site; t was 98.8; pt given apap; pt had tactile fever & arm was jerking; pt taken to Hosp & later had 2 sz; pt tx w/ apap;
Approximately 2 weeks after getting the 1st dose of vaccination I noticed bilateral lower leg rash which eventually turned out be leukocytoclastic vasculitis after medical work-up
I was nauseated, total fatigue, terrible cough, elevated temperature and runny nose. Today I feel better than I have in several days.  Contacted doctor via phone and she sent in a prescription to my pharmacy.